首页> 外国专利> INHIBITION OF BIOSYNTHESIS OF TUMOUR NECROSIS FACTOR (TNF) BY ADMINISTERING THE DIMERISED FROM OF LYSOZYME; FORMULATIONS CONTAINING LYSOZYME AND AN ANTIBIOTIC

INHIBITION OF BIOSYNTHESIS OF TUMOUR NECROSIS FACTOR (TNF) BY ADMINISTERING THE DIMERISED FROM OF LYSOZYME; FORMULATIONS CONTAINING LYSOZYME AND AN ANTIBIOTIC

机译:抑制溶菌酶的二聚体抑制肿瘤坏死因子的生物合成;包含溶菌酶和抗生素的制剂

摘要

Dimerized lysozyme is used prophylactically or as a treatment for diseases associated with Tumor Necrosis Factor. Administration of the dimerized lysozyme by mouth, injection, an impregnated tampon, an antiseptive dressing, a gel or an ointment results in lowered Tumor Necrosis Factor concentrations. Therapy proved to be effective and very simple in the treatment of diseases which have a multi-factor etiology and pathogenesis.
机译:二聚溶菌酶可用于预防或治疗与肿瘤坏死因子相关的疾病。通过口服,注射,浸渍的棉塞,抗脓性敷料,凝胶或软膏剂施用二聚溶菌酶会降低肿瘤坏死因子的浓度。事实证明,该疗法在治疗具有多因素病因和发病机制的疾病方面非常有效且非常简单。

著录项

  • 公开/公告号NZ254135A

    专利类型

  • 公开/公告日1996-11-26

    原文格式PDF

  • 申请/专利权人 NIKA HEALTH PRODUCTS LTD;

    申请/专利号NZ19930254135

  • 发明设计人 KICZKA WITOLD;

    申请日1993-07-13

  • 分类号A61K38/46;C12N9/36;

  • 国家 NZ

  • 入库时间 2022-08-22 03:26:07

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号